Informationen:
Fehler:
ID
33980
Beschreibung
A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00883779
Link
https://clinicaltrials.gov/show/NCT00883779
Stichworte
Versionen (1)
- 09.01.19 09.01.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
9. Januar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00883779
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00883779
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00883779
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Adult | Age
Item
adult patients, >=18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging
Item
advanced (stage iiib/iv)non-small cell lung cancer;
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Measurable Disease
Item
measurable disease;
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Exposure to Pharmaceutical Preparations Targeting Epidermal Growth Factor Receptor
Item
prior exposure to agents directed at the her axis;
boolean
C0332157 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C1521840 (UMLS CUI [1,3])
C0034802 (UMLS CUI [1,4])
C0013227 (UMLS CUI [1,2])
C1521840 (UMLS CUI [1,3])
C0034802 (UMLS CUI [1,4])
Prior Chemotherapy | Cancer treatment Systemic | Status post Advanced disease
Item
prior chemotherapy or systemic anti-tumor therapy after advanced disease;
boolean
C1514457 (UMLS CUI [1])
C0920425 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0679246 (UMLS CUI [3,2])
C0920425 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0679246 (UMLS CUI [3,2])
Systemic disease Unstable
Item
unstable systemic disease;
boolean
C0442893 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,2])
Cancer Other | Exception Basal cell carcinoma Cured | Exception Carcinoma in situ of uterine cervix Cured
Item
any other malignancy within last 5 years, except cured basal cell cancer of skin or cured cancer in situ of cervix;
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1880198 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1880198 (UMLS CUI [3,3])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1880198 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1880198 (UMLS CUI [3,3])
Metastatic malignant neoplasm to brain | Compression of spinal cord
Item
brain metastasis or spinal cord compression.
boolean
C0220650 (UMLS CUI [1])
C0037926 (UMLS CUI [2])
C0037926 (UMLS CUI [2])